Charles R. Scheper-Chairman of the Board
Mr. Chuck Scheper was the Chief Operating Officer at Great American Financial Resources, a $20 billion life and annuity company until his retirement in 2010. Prior to that position, Mr. Scheper was president and chief executive officer of Manhattan National Life Insurance Company and president of Pioneer Financial Services. Chuck is a cancer survivor and his journey to wellness led him to become active in various causes related to cancer, including Cancer Support Community, where he has served as the National Board Chairperson and board member. Currently, he is also the Chair of Catalytic Development Funding Corp of Northern Kentucky and Covington Economic Development Authority.
William P. Butler-Board Member
Mr. Bill Butler serves as Chairman of Corporex Companies LLC, a diversified real estate company with more than $1 billion of real estate assets that he founded. He continues to set strategy and provide vision as he has done for the companies since 1965. Dedicated to community service he serves on the Board of Directors for United Way of Greater Cincinnati, Lindner Center of HOPE, Dan Beard Council of the Boy Scouts of America, and The Butler Foundation.
Cameron Durrant, MD, MBA-Board Member
Dr. Cameron Durrant is the Chairman and Chief Executive Officer of Humanigen. He has held executive positions at major global pharmaceutical companies, including Merck & Co., GlaxoSmithKline and Pharmacia. Dr. Durrant has served as board chairman, lead independent director and as CEO for several specialty pharma or biotech companies in both the private and public sector. He has been involved in several exits and has raised significant funding from a variety of sources.
Ray Takigiku, PhD –President and CEO
Dr. Ray Takigiku is an entrepreneurial life sciences executive with substantial experience in the discovery, development and market support of novel drugs. At Procter and Gamble Pharmaceuticals, Dr. Takigiku led and built global R&D functions that helped grow P&G’s Health Care segment to almost $8B with double digit earnings, including the discovery, development and launch of the blockbuster osteoporosis drug, Actonel. He was also co-director of the Genome Research Institute at the College of Medicine, University of Cincinnati. In 2006, Dr. Takigiku co-founded Bexion Pharmaceuticals, now developing first-in-class oncology products with potential to treat gliomas and other deadly tumors.
Timothy Schroeder-Board Member
Timothy Schroeder, CEO and Founder of CTI Clinical Trial and Consulting Services, has over 35 years of clinical, academic, and industry experience in global drug and device development programs. CTI, founded in 1999, is a multi-national clinical research firm with associates in North America, Europe, Latin America and Asia-Pacific. The firm, which is one of the 20 largest CROs in the world, has supported more than 100 drug and device approvals and currently works on behalf of approximately 135 global pharmaceutical and biotechnology companies.
Raymond J. Tesi, M.D.-Board Member
Dr. Tesi has a distinguished career as a biotech entrepreneur and an experienced surgeon. Currently, he is President, Chief Executive Officer and acting Chief Medical Officer of INmune Bio (NASDAQ: INMB). Prior to his role at INMB, he held leadership positions in several biotech companies in both the development and commercial sides of the businesses with responsibility for all phases of drug development, product positioning and launch, post-approval marketing support, while supporting investor relations and business development. Dr. Tesi has been an academic transplant surgeon since 1982, receiving his MD degree from Washington University School of Medicine, and has been a Fellow of the American College of Surgery since 1991.
Olivia F. Kirtley, CPA, CGMA – Board Member
Ms. Olivia Kirtley, a Certified Public Accountant and Chartered Global Management Accountant, is a highly experienced business consultant on strategic, risk and corporate governance issues. Her career spans tenures as a corporate executive and public accounting, including as Chief Financial Officer of an international company and senior tax manager at a predecessor firm to Ernst & Young. Ms. Kirtley is also a recognized leader of the accountancy profession in the U. S. and globally, having served as President and Chairman of the International Federation of Accountants (IFAC) and Chairman of the American Institute of Certified Public Accountants (AICPA). She has extensive public and private company board experience and is currently a director of U.S. Bancorp and Papa John’s International.
Lester Crawford, D.V.M.-Board Member Emeritus
Dr. Lester Crawford has had a distinguished career in the public and private sectors, as well as academia. He has served as FDA Commissioner and as Administrator of the Food Safety & Inspection Service at USDA. He has been an expert advisor to the World Health Organization, the Singapore FDA, and the U.S. National Academy of Sciences. Dr. Crawford is a Member of the Institute of Medicine of the National Academy of Sciences, a Fellow of the Royal Society of Medicine in the United Kingdom, and a Fellow of the International Society of Food Science and Technology.